Home › Lilly stops mid-stage Alzheimer's drug study
 

Keywords :   


Lilly stops mid-stage Alzheimer's drug study

2013-06-14 01:25:39| Biotech - Topix.net

Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because of potential side effects on patients' livers.

Tags: study drug stops lilly

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.10Mark Andy appoints Antony Cotton European sales manager
07.10Hurricane Milton Potential Storm Surge Flooding Map
07.10Evonik, BASF Agree on First Delivery of Biomass-Balanced Ammonia
07.10Hurricane Milton Update Statement
07.10Summary for Hurricane Milton (AT4/AL142024)
07.10Hurricane Milton Probabilistic Storm Surge Graphics
07.10MCC acquires smart label solutions provider Starport Technologies
07.10UPM Raflatac announces Packaging Recyclability Guide
More »